NOS2 and cancer: When SR/CR Nos2-/- macrophages and neutrophils were transferred into cancer-sensitive WT mice, the SR/CR Nos2-/- cells proved to be less protective against an S180 challenge compared to cells from SR/CR Nos2+/+ mice.